FENTA SL 67 SUBLINGUAL TABLETS Ísrael - enska - Ministry of Health

fenta sl 67 sublingual tablets

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

FENTA SL 67 SUBLINGUAL TABLETS Ísrael - enska - Ministry of Health

fenta sl 67 sublingual tablets

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

PENTASA SLOW RELEASE TABLETS 1 GRAM Ísrael - enska - Ministry of Health

pentasa slow release tablets 1 gram

ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 1 g - mesalazine - mild to moderate ulcerative colitis. crohn's disease.

RIZALT 10 MG TABLETS Ísrael - enska - Ministry of Health

rizalt 10 mg tablets

organon pharma israel ltd., israel - rizatriptan as benzoate - tablets - rizatriptan as benzoate 10 mg - rizatriptan - rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.

RUPAFIN TABLETS Ísrael - enska - Ministry of Health

rupafin tablets

kamada ltd, israel - rupatadine as fumarate - tablets - rupatadine as fumarate 10 mg - rupatadine - rupafin is indicated for symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents (over 12 years of age)

SERICOLD Tablets 500+30+5+2 mg Tansanía - enska - Tanzania Medicinces & Medical Devices Authority

sericold tablets 500+30+5+2 mg

shayana healthcare private limited, india - cough suppressants , expectorants - tablets - 500+30+5+2 mg

PRAMIN TABLETS Ísrael - enska - Ministry of Health

pramin tablets

rafa laboratories ltd - metoclopramide hydrochloride - tablets - metoclopramide hydrochloride 10 mg - metoclopramide - metoclopramide - metoclopramide is an antiemetic and stimulates gi motility. adult population :pramin is indicated in adults for: - prevention of postoperative nausea and vomiting (ponv)- prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv)- prevention of nausea and vomiting caused by radiation therapy- symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. in migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption.- diabetic gastroparesis pediatric population:pramin is indicated in children aged 1 to 18 years for: - second line-therapy: treatment of established postoperative nausea and vomiting (ponv)- second-line therapy: prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv)

ZOFRAN TABLETS 8 MG Ísrael - enska - Ministry of Health

zofran tablets 8 mg

novartis israel ltd - ondansetron as hydrochloride dihydrate - tablets - ondansetron as hydrochloride dihydrate 8 mg - ondansetron - ondansetron - adults:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.

ZOFRAN TABLETS 4 MG Ísrael - enska - Ministry of Health

zofran tablets 4 mg

novartis israel ltd - ondansetron as hydrochloride dihydrate - tablets - ondansetron as hydrochloride dihydrate 4 mg - ondansetron - ondansetron - adults:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy.

PENTASA SLOW RELEASE TABLETS 500 MG Ísrael - enska - Ministry of Health

pentasa slow release tablets 500 mg

ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 500 mg - mesalazine - mesalazine - mild to moderate ulcerative colitis.crohn's disease